Cargando…
A NK Cell Odyssey: From Bench to Therapeutics Against Hematological Malignancies
In 1975 two independent groups noticed the presence of immune cells with a unique ability to recognize and eliminate transformed hematopoietic cells without any prior sensitization or expansion of specific clones. Since then, NK cells have been the axis of thousands of studies that have resulted unt...
Autores principales: | Ramos-Mejia, Veronica, Arellano-Galindo, Jose, Mejía-Arangure, Juan Manuel, Cruz-Munoz, Mario Ernesto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046543/ https://www.ncbi.nlm.nih.gov/pubmed/35493522 http://dx.doi.org/10.3389/fimmu.2022.803995 |
Ejemplares similares
-
Interaction Between MDSC and NK Cells in Solid and Hematological Malignancies: Impact on HSCT
por: Tumino, Nicola, et al.
Publicado: (2021) -
Genetic Engineering and Enrichment of Human NK Cells for CAR-Enhanced Immunotherapy of Hematological Malignancies
por: Soldierer, Maren, et al.
Publicado: (2022) -
Targeting T cells to treat atherosclerosis: odyssey from bench to bedside
por: Bullenkamp, Jessica, et al.
Publicado: (2016) -
CAR-NK cell therapeutics for hematologic malignancies: hope is on the horizon
por: Xu, Kai-lin, et al.
Publicado: (2019) -
NK Cells in the Treatment of Hematological Malignancies
por: Gonzalez-Rodriguez, Ana P, et al.
Publicado: (2019)